RxDoctor Payments DataLook up a doctor →

Bharathi Raju, MD

Endocrinology, Diabetes & Metabolism · Saint Louis, MONPI 1720078843

Payments from drug & device makers

$52,856in general payments, 2019–2025

Across 1,042 payments — averaging $50.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$29K
  • Tandem Diabetes Care, Inc.$6K
  • Insulet Corporation$3K
  • Novo Nordisk$2K
  • Abbott$2K
  • Lilly USA, LLC$1K
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS23$28,970
Tandem Diabetes Care, Inc.25$6,324
Insulet Corporation36$2,762
Novo Nordisk159$2,064
Abbott126$1,618
Lilly USA, LLC91$1,309
Amgen56$920
Mannkind Corporation68$894
Amarin Pharma, Inc.34$524
Boehringer Ingelheim26$463
Antares Pharma, Inc.31$460
Bayer28$453
Sanofi-aventis U.S. LLC23$435
Nevro Corp.19$367
IBSA Pharma Inc.19$323
Novartis17$313
AstraZeneca(2 entities)19$313
Kowa Pharmaceuticals America, Inc.22$310
Medtronic(2 entities)21$302
Recordati_rare_diseases_inc.13$294
Corcept Therapeutics15$272
Xeris Pharmaceuticals, Inc.13$263
Esperion Therapeutics, Inc.18$246
Dexcom, Inc.10$179
AbbVie9$167
Merck10$148
BETA Bionics, Inc.11$146
Clarus Therapeutics Inc.7$143
Radius Health, Inc.7$136
Amneal Pharmaceuticals LLC8$133
Madrigal Pharmaceuticals6$124
Amphastar Pharmaceuticals, Inc.6$119
Johnson & Johnson7$114
Ascensia Diabetes Care US Inc.5$95
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$94
Lifescan, Inc.5$90
Pfizer5$85
Companion Medical, Inc.3$85
Sequel Med Tech, LLC3$81
Ascendis Pharma Endocrinology Inc3$75
Acella Pharmaceuticals, LLC4$72
Verity Pharmaceuticals Inc.1$69
Globus Medical1$58
Valeritas, Inc.3$57
Optos, Inc.2$45
Echosens North America, Inc.2$38
Itamar Medical Inc1$35
Averitas Pharma Inc.2$34
Sandoz1$31
Senseonics, Incorporated2$29
Kyowa Kirin, Inc.1$22
Embecta Corp.1$21
Halozyme Inc1$20
Rhythm Pharmaceuticals, Inc.1$19
Currax Pharmaceuticals LLC1$17
Zealand Pharma US, Inc.1$14
Topcon Healthcare Solutions, Inc.1$14
Amryt Pharma Holdings Ltd1$14
Shire North American Group Inc1$14
Acerus Pharmaceuticals Corporation1$13

How this compares

$52,856 in reported general payments places this provider in the 80th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.

See all endocrinology, diabetes & metabolism providers in Missouri →

Medicare billing

Part B allowed, 2024
$228,504
Medicare patients
516
Services billed
3,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →